Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31true2false2024-04-01falseSpecialists medical practice activities2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 05780109 2024-04-01 2025-03-31 05780109 2023-04-01 2024-03-31 05780109 2025-03-31 05780109 2024-03-31 05780109 2023-04-01 05780109 c:Director1 2024-04-01 2025-03-31 05780109 d:OfficeEquipment 2024-04-01 2025-03-31 05780109 d:OfficeEquipment 2025-03-31 05780109 d:OfficeEquipment 2024-03-31 05780109 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05780109 d:CurrentFinancialInstruments 2025-03-31 05780109 d:CurrentFinancialInstruments 2024-03-31 05780109 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 05780109 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 05780109 d:ShareCapital 2025-03-31 05780109 d:ShareCapital 2024-03-31 05780109 d:RetainedEarningsAccumulatedLosses 2025-03-31 05780109 d:RetainedEarningsAccumulatedLosses 2024-03-31 05780109 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 05780109 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 05780109 c:OrdinaryShareClass3 2024-04-01 2025-03-31 05780109 c:OrdinaryShareClass3 2025-03-31 05780109 c:OrdinaryShareClass3 2024-03-31 05780109 c:OrdinaryShareClass4 2024-04-01 2025-03-31 05780109 c:OrdinaryShareClass4 2025-03-31 05780109 c:OrdinaryShareClass4 2024-03-31 05780109 c:OrdinaryShareClass5 2024-04-01 2025-03-31 05780109 c:OrdinaryShareClass5 2025-03-31 05780109 c:OrdinaryShareClass5 2024-03-31 05780109 c:FRS102 2024-04-01 2025-03-31 05780109 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05780109 c:FullAccounts 2024-04-01 2025-03-31 05780109 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05780109 2 2024-04-01 2025-03-31 05780109 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 05780109









CAMBRIDGE EYE CLINIC LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
CAMBRIDGE EYE CLINIC LIMITED
REGISTERED NUMBER: 05780109

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2025
2024
2024
Note
£
£
£
£

FIXED ASSETS
  

Tangible assets
 4 
1,988
2,721

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
459,475
389,854

Cash at bank and in hand
  
784,337
786,232

  
1,243,812
1,176,086

Creditors: amounts falling due within one year
 6 
(75,393)
(98,340)

NET CURRENT ASSETS
  
 
 
1,168,419
 
 
1,077,746

TOTAL ASSETS LESS CURRENT LIABILITIES
  
1,170,407
1,080,467

PROVISIONS FOR LIABILITIES
  

Deferred tax
 7 
(497)
(680)

NET ASSETS
  
1,169,910
1,079,787


CAPITAL AND RESERVES
  

Called up share capital 
 8 
2
2

Profit and loss account
  
1,169,908
1,079,785

  
1,169,910
1,079,787


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

 
CAMBRIDGE EYE CLINIC LIMITED
REGISTERED NUMBER: 05780109
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




C G Stephenson
Director

Date: 11 August 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


GENERAL INFORMATION

Cambridge Eye Clinic Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is Salisbury House, Station Road, Cambridge, CB1 2LA.
The principal place of business is 36 Northrop Road, Trumpington, Cambridge, CB2 9DD.
The Company's functional and presentational currency is GBP.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

TURNOVER

Turnover comprises revenue recognised by the Company in respect of specialist clinical ophthalmology services during the year, exclusive of Value Added Tax. Revenue is recognised as the fair value of the consideration received or receivable and is recognised based on the date the work was performed.

 
2.3

INTEREST INCOME

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

CURRENT AND DEFERRED TAXATION

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.5

PENSIONS

The Company contributes to the personal pension plan of one of the directors. Contributions are recognised in the year in which they are paid.

 
2.6

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.7

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

DIVIDENDS

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

Page 5

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


TANGIBLE FIXED ASSETS





Office equipment

£



COST OR VALUATION


At 1 April 2024
10,991


Additions
942


Disposals
(1,175)



At 31 March 2025

10,758



DEPRECIATION


At 1 April 2024
8,270


Charge for the year on owned assets
1,675


Disposals
(1,175)



At 31 March 2025

8,770



NET BOOK VALUE



At 31 March 2025
1,988



At 31 March 2024
2,721


5.


DEBTORS

2025
2024
£
£


Trade debtors
56,998
25,900

Other debtors
303,592
338,649

Prepayments and accrued income
-
25,305

Tax recoverable
98,885
-

459,475
389,854


Page 6

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025
2024
£
£

Trade creditors
433
1,404

Corporation tax
67,991
89,067

Other taxation and social security
757
757

Other creditors
785
3,210

Accruals and deferred income
5,427
3,902

75,393
98,340



7.


DEFERRED TAXATION




2025
2024


£

£






At beginning of year
680
574


Charged to profit or loss
(183)
106



AT END OF YEAR
497
680

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
497
680


8.


SHARE CAPITAL

2025
2024
£
£
ALLOTTED, CALLED UP AND FULLY PAID



90 (2024 - 90) Ordinary shares of £0.01 each
0.90
0.90
90 (2024 - 90) A Ordinary shares of £0.01 each
0.90
0.90
20 (2024 - 20) B Ordinary shares of £0.01 each
0.20
0.20

2.00

2.00


Page 7

 
CAMBRIDGE EYE CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


TRANSACTIONS WITH DIRECTORS

During the year the Company made advances to the directors totalling £40,000 (2024 - £345,000) and received repayments of £75,000 (2024 - £NIL). Interest is being paid to the Company on the overdrawn loan at the HMRC official rate of interest. The overdrawn loan balance at the balance sheet date amounted to £302,680 (2024 - £337,992).

 
Page 8